Ana-Marta Silva

Professor

Instituto Universitário de Ciências da Saúde

Portugal

Research Interests

Explore related searches

Professors in Portugal

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (3)

Jorge Polonia

Professor Catedrático

Universidade do Porto Faculdade de Medicina

PORTUGAL

View details

João Bernardes

Professor Catedrático

Universidade do Porto Faculdade de Medicina

PORTUGAL

View details

Manuela Morato

Professora Auxiliar

Universidade do Porto Faculdade de Medicina

PORTUGAL

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ana-Marta Silva

Research Interests

Explore related searches

Contact this professor

Articles (10)

Embracing Uncertainties Over the Evidence of New Oral Antivirals for COVID‐19: Challenges in Pharmacoepidemiologic Research

Motivation and Knowledge of Portuguese Community Pharmacists Towards the Reporting of Suspected Adverse Reactions to Medicines: A Cross-Sectional Survey

Abstracts Presented at the 2022 International Pharmacoeconomics Forum

Farmacovigilância das Vacinas contra a COVID-19 Durante a Gravidez e a Amamentação

Delayed Extensive Local Reactions: a case series to the mRNA-1273 vaccine against SARS-CoV-2

PDG17 Adverse Drug Reactions Associated to Hydroxychloroquine and Remdesivir in COVID-19 Patients: Analysis of Reported ADR to the Portuguese Pharmacovigilance System

PNS22 Real-World DATA of ADR Reports in Signal Detection - DME Perspective

The Role of Pharmacovigilance in the COVID-19 Pandemic

Retrospectiva de 20 anos de atividade da Unidade de Farmacovigilância do Porto, Portugal

PNS48 ADR Report By Consumers in Portugal: 8 YEARS of Experience

Collaborators (3)

Jorge Polonia

João Bernardes

Manuela Morato

Make your next move.